0001225208-13-025231.txt : 20131211
0001225208-13-025231.hdr.sgml : 20131211
20131211182850
ACCESSION NUMBER: 0001225208-13-025231
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20131209
FILED AS OF DATE: 20131211
DATE AS OF CHANGE: 20131211
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BARD C R INC /NJ/
CENTRAL INDEX KEY: 0000009892
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 221454160
STATE OF INCORPORATION: NJ
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 730 CENTRAL AVE
CITY: MURRAY HILL
STATE: NJ
ZIP: 07974
BUSINESS PHONE: 9082778000
MAIL ADDRESS:
STREET 1: 730 CENTRAL AVENUE
CITY: MURRAY HILL
STATE: NJ
ZIP: 07974
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: WEILAND JOHN H
CENTRAL INDEX KEY: 0001204663
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-06926
FILM NUMBER: 131272035
MAIL ADDRESS:
STREET 1: C/O C.R BARD INC
STREET 2: 730 CENTRAL AVE
CITY: MURRAY HILL
STATE: NJ
ZIP: 07974
4
1
doc4.xml
X0306
4
2013-12-09
0000009892
BARD C R INC /NJ/
BCR
0001204663
WEILAND JOHN H
C/O C. R. BARD, INC.
730 CENTRAL AVENUE
MURRAY HILL
NJ
07974
1
1
President and COO
Common Stock
2013-12-09
4
F
0
10062.0000
137.6800
D
134383.2900
D
Common Stock
2013-12-10
4
S
0
1900.0000
137.8953
D
132483.2900
D
Common Stock
2013-12-10
4
S
0
8489.0000
137.1615
D
123994.2900
D
Common Stock
5573.5030
I
401(k) Plan
Shares withheld to pay taxes upon vesting of restricted stock granted under the Company's 2003 Long Term Incentive Plan.
Sales are pursuant to a previously disclosed 10b5-1 plan.
Represents the weighted average sales price for price increments ranging from $137.85 to $137.95. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4.
Represents the weighted average sales price for price increments ranging from $136.80 to $137.76. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4.
Includes 5.358 shares acquired under the Company's 401(k) Plan from August 13, 2013 to December 9, 2013.
Myra McGinley, Attorney-in-Fact
2013-12-11